Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
262.4 USD | +1.65% | +12.21% | +19.33% |
05-03 | United Therapeutics Insider Sold Shares Worth $1,829,903, According to a Recent SEC Filing | MT |
05-02 | UBS Adjusts Price Target on United Therapeutics to $300 From $290, Maintains Buy Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+19.33% | 11.64B | |
+25.69% | 47.86B | |
+46.90% | 41.42B | |
-3.46% | 40.66B | |
-6.20% | 28.92B | |
+9.17% | 25.55B | |
-20.42% | 19.27B | |
+28.07% | 12.14B | |
+0.17% | 12.15B | |
-1.24% | 11.99B |
- Stock Market
- Equities
- UTHR Stock
- News United Therapeutics Corporation
- United Therapeutics Gets US FDA Nod for Pulmonary Arterial Hypertension Treatment -- Stock Rises